Related Experiment Video
Updated: Mar 2, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Sudden cardiac death in inherited cardiomyopathy
1Institute of Cardiovascular Science, University College London, Gower Street, London WC1E 6BT, United Kingdom.
Insights
Cardiomyopathy increases sudden cardiac death risk in young people. Thorough clinical assessment identifies at-risk individuals for prophylactic implantable cardioverter-defibrillator (ICD) therapy.
Area of Science:
- Cardiology
- Sudden Cardiac Death Research
Background:
- Cardiomyopathy is a significant cause of sudden cardiac death (SCD), especially in adolescents and young adults.
- The risk of SCD in cardiomyopathy varies based on disease type, severity, age, and gender.
Purpose of the Study:
- To emphasize the critical role of systematic clinical assessment in managing cardiomyopathy.
- To identify individuals at high risk for SCD who may benefit from prophylactic therapy.
Main Methods:
- Review of clinical management strategies for cardiomyopathy.
- Analysis of risk factors contributing to sudden cardiac death in various cardiomyopathies.
Main Results:
- Sudden cardiac death risk is heterogeneous among cardiomyopathy types.
- Age and gender are important determinants of SCD risk.
- Prophylactic implantable cardioverter-defibrillator (ICD) therapy can protect select high-risk individuals.
Conclusions:
- A thorough clinical evaluation is fundamental for managing cardiomyopathy.
- Early identification of high-risk patients is crucial for preventing SCD.
- Prophylactic ICD implantation is a key strategy for at-risk individuals.
Abstract:
Cardiomyopathy is an important cause of sudden cardiac death particularly in adolescents and young adults. The risk of sudden cardiac death varies between individual cardiomyopathies and is dependent on the severity of disease, age and gender. Although rare in cardiomyopathies, a fundamental aspect of clinical management is a systematic and thorough clinical assessment to identify the small number of individuals who are at risk and who can be protected with prophylactic ICD therapy.
More Related Videos
06:46Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Cardiomyopathy V: Interprofessional Care